Joel Linden, PhD

University of Virginia
Charlottesville, Virginia, United States

Disclosure information not submitted.

Presentation(s):

• 77 - Targeting Adenosine A2B Receptor to Prevent Post-Clostridioides difficile Infection-associated Gastrointestinal Dysfunction

  Monday, October 20, 2025
  11:06 AM - 11:18 AM US ET